KYMR: Kymera Therapeutics Maintained Outperform by RBC Capital Feb 26 2026
RBC Capital maintained KYMR analyst rating at Outperform and raised PT to $108 on Feb 26 2026; implications and Meyka AI grade B+
RBC Capital maintained KYMR analyst rating at Outperform and raised PT to $108 on Feb 26 2026; implications and Meyka AI grade B+
SBLI.BO stock jumps 20% pre-market to INR 42.60 on 27 Feb 2026; we outline drivers, valuation and Meyka AI forecast
Jimmy Lai appeal: What Hong Kong’s rare court reversal signals for rule of law, press freedom, and risk premia. Actionable takeaways for Singapore investors today.
Pre-market update on ZEHN.SW stock: down 6.80% to CHF 79.50 on 27 Feb 2026 with volume surge and oversold technicals
Pre-market top gainer: 1421.HK stock jumps 13.43% to HK$0.38; Meyka AI grade, forecast and volume explained
Pre-market: 18P0.F stock jumps 33.96% to €0.71 on XETRA; key metrics, Meyka grade and a €0.60 monthly forecast
Meghalaya police to issue 3,000 appointment letters from Feb 27, confirmed by Prestone Tynsong. Impact on budgets, vendors, and investors with timelines, risks, and tender watchpoints.
Pre-market volume spike for N08.SI stock on 27 Feb 2026; 10,000 shares traded and **S$0.235** price — analysis and short-term forecast
Intraday: LRS.AX stock trades A$0.165 on 44.89M volume; Meyka AI grade C+ and model forecasts inside
Borge Brende resignation triggers a WEF leadership change in Switzerland. Alois Zwinggi is interim. We explain what this means for Davos access, reputational risk, and investor watchpoints for 2026.